These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35490971)

  • 1. Long-term directional deep brain stimulation: Monopolar review vs. local field potential guided programming.
    Fernández-García C; Monje MHG; Gómez-Mayordomo V; Foffani G; Herranz R; Catalán MJ; González-Hidalgo M; Matias-Guiu J; Alonso-Frech F
    Brain Stimul; 2022; 15(3):727-736. PubMed ID: 35490971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local Field Potentials Predict Motor Performance in Deep Brain Stimulation for Parkinson's Disease.
    Busch JL; Kaplan J; Bahners BH; Roediger J; Faust K; Schneider GH; Florin E; Schnitzler A; Krause P; Kühn AA
    Mov Disord; 2023 Dec; 38(12):2185-2196. PubMed ID: 37823518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Directional local field potentials: A tool to optimize deep brain stimulation.
    Tinkhauser G; Pogosyan A; Debove I; Nowacki A; Shah SA; Seidel K; Tan H; Brittain JS; Petermann K; di Biase L; Oertel M; Pollo C; Brown P; Schuepbach M
    Mov Disord; 2018 Jan; 33(1):159-164. PubMed ID: 29150884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative Local Field Potential Beta Power and Three-Dimensional Neuroimaging Mapping Predict Long-Term Clinical Response to Deep Brain Stimulation in Parkinson Disease: A Retrospective Study.
    di Biase L; Piano C; Bove F; Ricci L; Caminiti ML; Stefani A; Viselli F; Modugno N; Cerroni R; Calabresi P; Bentivoglio AR; Tufo T; Di Lazzaro V;
    Neuromodulation; 2023 Dec; 26(8):1724-1732. PubMed ID: 36774326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subthalamic local field potential oscillations during ongoing deep brain stimulation in Parkinson's disease.
    Rossi L; Marceglia S; Foffani G; Cogiamanian F; Tamma F; Rampini P; Barbieri S; Bracchi F; Priori A
    Brain Res Bull; 2008 Jul; 76(5):512-21. PubMed ID: 18534260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards guided and automated programming of subthalamic area stimulation in Parkinson's disease.
    Xu SS; Sinclair NC; Bulluss KJ; Perera T; Lee WL; McDermott HJ; Thevathasan W
    Brain Commun; 2022; 4(1):fcac003. PubMed ID: 35169708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Directional Local Field Potentials in the Subthalamic Nucleus During Deep Brain Implantation of Parkinson's Disease Patients.
    Nguyen TAK; Schüpbach M; Mercanzini A; Dransart A; Pollo C
    Front Hum Neurosci; 2020; 14():521282. PubMed ID: 33192384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The guiding effect of local field potential during deep brain stimulation surgery for programming in Parkinson's disease patients.
    Dong W; Qiu C; Chang L; Sun J; Yan J; Luo B; Lu Y; Liu W; Zhang L; Zhang W
    CNS Neurosci Ther; 2024 Apr; 30(4):e14501. PubMed ID: 37830232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Directional Recording of Subthalamic Spectral Power Densities in Parkinson's Disease and the Effect of Steering Deep Brain Stimulation.
    Bour LJ; Lourens MA; Verhagen R; de Bie RM; van den Munckhof P; Schuurman PR; Contarino MF
    Brain Stimul; 2015; 8(4):730-41. PubMed ID: 25753176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Directional stimulation of subthalamic nucleus sweet spot predicts clinical efficacy: Proof of concept.
    Nguyen TAK; Nowacki A; Debove I; Petermann K; Tinkhauser G; Wiest R; Schüpbach M; Krack P; Pollo C
    Brain Stimul; 2019; 12(5):1127-1134. PubMed ID: 31130498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High frequency oscillations in the subthalamic nucleus: a neurophysiological marker of the motor state in Parkinson's disease.
    Özkurt TE; Butz M; Homburger M; Elben S; Vesper J; Wojtecki L; Schnitzler A
    Exp Neurol; 2011 Jun; 229(2):324-31. PubMed ID: 21376039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subthalamic span of beta oscillations predicts deep brain stimulation efficacy for patients with Parkinson's disease.
    Zaidel A; Spivak A; Grieb B; Bergman H; Israel Z
    Brain; 2010 Jul; 133(Pt 7):2007-21. PubMed ID: 20534648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-Time Neurofeedback to Modulate β-Band Power in the Subthalamic Nucleus in Parkinson's Disease Patients.
    Fukuma R; Yanagisawa T; Tanaka M; Yoshida F; Hosomi K; Oshino S; Tani N; Kishima H
    eNeuro; 2018; 5(6):. PubMed ID: 30627648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients.
    Merola A; Zibetti M; Angrisano S; Rizzi L; Ricchi V; Artusi CA; Lanotte M; Rizzone MG; Lopiano L
    Brain; 2011 Jul; 134(Pt 7):2074-84. PubMed ID: 21666262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sevoflurane and Parkinson's Disease: Subthalamic Nucleus Neuronal Activity and Clinical Outcome of Deep Brain Stimulation.
    Tsai ST; Tseng GF; Kuo CC; Chen TY; Chen SY
    Anesthesiology; 2020 May; 132(5):1034-1044. PubMed ID: 32044799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Directional DBS increases side-effect thresholds-A prospective, double-blind trial.
    Dembek TA; Reker P; Visser-Vandewalle V; Wirths J; Treuer H; Klehr M; Roediger J; Dafsari HS; Barbe MT; Timmermann L
    Mov Disord; 2017 Oct; 32(10):1380-1388. PubMed ID: 28843009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization.
    Garcia-Garcia D; Guridi J; Toledo JB; Alegre M; Obeso JA; Rodríguez-Oroz MC
    J Neurosurg; 2016 Nov; 125(5):1068-1079. PubMed ID: 26848922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subthalamic beta oscillations are attenuated after withdrawal of chronic high frequency neurostimulation in Parkinson's disease.
    Trager MH; Koop MM; Velisar A; Blumenfeld Z; Nikolau JS; Quinn EJ; Martin T; Bronte-Stewart H
    Neurobiol Dis; 2016 Dec; 96():22-30. PubMed ID: 27553876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programming parameters of subthalamic deep brain stimulators in Parkinson's disease from a controlled trial.
    Knudsen K; Krack P; Tonder L; Houeto JL; Rau J; Schade-Brittinger C; Hartmann A; Hälbig TD; Paschen S; Barbe MT; Kühn A; Fraix V; Brefel-Courbon C; Vesper J; Maltête D; Sixel-Döring F; Weiss D; Witjas T; Thobois S; Agid Y; Schnitzler A; Schuepbach WMM; Timmermann L; Damier P; Vidailhet M; Deuschl G;
    Parkinsonism Relat Disord; 2019 Aug; 65():217-223. PubMed ID: 31257096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative test stimulation of the subthalamic nucleus aids postoperative programming of chronic stimulation settings in Parkinson's disease.
    Geraedts VJ; van Ham RAP; Marinus J; van Hilten JJ; Mosch A; Hoffmann CFE; van der Gaag NA; Contarino MF
    Parkinsonism Relat Disord; 2019 Aug; 65():62-66. PubMed ID: 31105015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.